A staged approach for a patient decision aid was found to facilitate shared decision-making for adults with atopic dermatitis.

Avalo Therapeutics (NASDAQ:AVTX) is preparing to report phase IIb data in the second quarter of 2026 from its LOTUS trial evaluating AVTX-009 in hidradenitis suppurativa (HS), CEO Garry Neil said ...

The S&P 600 SmallCap index offers select high-yield 'dividend dogs' with analyst-projected net gains of 31% to 61% by ...

Piper Sandler Virtual Novel Targets in Immunology Symposium February 13, 2026 10:00 AM ESTCompany ParticipantsRoopal Thakkar - ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

Arcjet today announced the release of v1.0 of its Arcjet JavaScript SDK, marking the transition from beta to a stable, production-ready API that teams can confidently adopt for the long term. After ...

Apparently, nothing says 'Neopets RPG' like casting Vicious Mockery on a group of bandits in a Dungeons and Dragons style dungeon crawl.

In 2020, as many as 5.8 million Americans were living with Alzheimer’s Disease (AD)—a number projected to nearly triple to 14 million people by 2060. 1 As changes in the brain can begin years before ...

Nothing Essential Apps beta has been announced by the company where one can build AI-based mini apps and widgets through a text prompt.

Nothing has begun rolling out the beta of its Playground platform, where users can create simple, task-specific apps using the Essential Apps Builder and deploy them without coding ...

Join the open beta weekend for Marathon's Server Slam, where players can get an early look at Bungie's upcoming extraction shooter.